BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 9512107)

  • 21. [Systemic sclerosis: a multisystem disease].
    Berrevoets MA; Markhorst J; Meek I; van Ede AE; Vonk MC
    Ned Tijdschr Geneeskd; 2014; 158():A7703. PubMed ID: 25052356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Associations with digital ulcers in a large cohort of systemic sclerosis: results from the Canadian Scleroderma Research Group registry.
    Khimdas S; Harding S; Bonner A; Zummer B; Baron M; Pope J;
    Arthritis Care Res (Hoboken); 2011 Jan; 63(1):142-9. PubMed ID: 20740608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Digital ulcers and cutaneous subsets of systemic sclerosis: Clinical, immunological, nailfold capillaroscopy, and survival differences in the Spanish RESCLE Registry.
    Tolosa-Vilella C; Morera-Morales ML; Simeón-Aznar CP; Marí-Alfonso B; Colunga-Arguelles D; Callejas Rubio JL; Rubio-Rivas M; Freire-Dapena M; Guillén-Del Castillo A; Iniesta-Arandia N; Castillo-Palma MJ; Egurbide-Arberas M; Trapiellla-Martínez L; Vargas-Hitos JA; Todolí-Parra JA; Rodriguez-Carballeira M; Marin-Ballvé A; Pla-Salas X; Rios-Blanco JJ; Fonollosa-Pla V;
    Semin Arthritis Rheum; 2016 Oct; 46(2):200-208. PubMed ID: 27312381
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of systemic sclerosis.
    Pope JE
    Rheum Dis Clin North Am; 1996 Nov; 22(4):893-907. PubMed ID: 8923602
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diffuse systemic sclerosis and related diseases in Thailand.
    Panicheewa S; Chitrabamrung S; Verasertniyom O; Vanichaphantu M; Kraisit SO; Chiewsilp P; Vatanasuk M
    Clin Rheumatol; 1991 Jun; 10(2):124-9. PubMed ID: 1914410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pulmonary involvement in systemic sclerosis (scleroderma).
    Steen VD; Owens GR; Fino GJ; Rodnan GP; Medsger TA
    Arthritis Rheum; 1985 Jul; 28(7):759-67. PubMed ID: 4015723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and evolution of scleroderma pattern at nailfold videocapillaroscopy in systemic sclerosis patients: Clinical and prognostic implications.
    Ghizzoni C; Sebastiani M; Manfredi A; Campomori F; Colaci M; Giuggioli D; Ferri C
    Microvasc Res; 2015 May; 99():92-5. PubMed ID: 25842153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sex and time to diagnosis in systemic sclerosis: an updated analysis of 1,129 patients from the Canadian scleroderma research group registry.
    Delisle VC; Hudson M; Baron M; Thombs BD; And The Canadian Scleroderma Research Group A
    Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-10-4. PubMed ID: 24144459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Classification criteria of scleroderma].
    Cabane J;
    Presse Med; 2006 Dec; 35(12 Pt 2):1916-22. PubMed ID: 17159717
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systemic Sclerosis and Pulmonary Disease.
    Ngo K
    Adv Exp Med Biol; 2021; 1303():173-182. PubMed ID: 33788193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database.
    Walker UA; Tyndall A; Czirják L; Denton C; Farge-Bancel D; Kowal-Bielecka O; Müller-Ladner U; Bocelli-Tyndall C; Matucci-Cerinic M
    Ann Rheum Dis; 2007 Jun; 66(6):754-63. PubMed ID: 17234652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Localized and systemic scleroderma.
    Hawk A; English JC
    Semin Cutan Med Surg; 2001 Mar; 20(1):27-37. PubMed ID: 11308134
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Care of patients with scleroderma in the intensive care setting.
    Farber HW; Simms RW; Lafyatis R
    J Intensive Care Med; 2010 Sep; 25(5):247-58. PubMed ID: 20542965
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progressive systemic sclerosis sine scleroderma in a child presenting as nocturnal seizures and Raynaud's phenomenon.
    Navon P; Halevi A; Brand A; Branski D; Rubinow A
    Acta Paediatr; 1993 Jan; 82(1):122-3. PubMed ID: 8453211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal involvement in scleroderma.
    Desai Y; Ghanekar MA; Siquera RD; Joshi VR
    J Assoc Physicians India; 1990 Oct; 38(10):768-70. PubMed ID: 2084079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of clonazepam on Raynaud's phenomenon and fingertip ulcers in scleroderma.
    Colakoğlu M; Cobankara V; Akpolat T
    Ann Pharmacother; 2007 Sep; 41(9):1544-7. PubMed ID: 17666574
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Botulinum toxin type A contribution in the treatment of Raynaud's phenomenon due to systemic sclerosis].
    Serri J; Legré R; Veit V; Guardia C; Gay AM
    Ann Chir Plast Esthet; 2013 Dec; 58(6):658-62. PubMed ID: 22204894
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systemic sclerosis sine scleroderma.
    Kucharz EJ; Kopeć-Mędrek M
    Adv Clin Exp Med; 2017 Aug; 26(5):875-880. PubMed ID: 29068586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systemic Sclerosis with Focus on Scleroderma Renal Crisis.
    Pasha F; Abazari S; Bikarannejad P; Zabolian A
    Iran J Kidney Dis; 2019 May; 13(3):207-210. PubMed ID: 31209194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Symptoms and esophageal motility based on phenotypic findings of scleroderma.
    Tang DM; Pathikonda M; Harrison M; Fisher RS; Friedenberg FK; Parkman HP
    Dis Esophagus; 2013; 26(2):197-203. PubMed ID: 22590983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.